BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Annerino DM, Arshad S, Taylor GM, Adler CH, Beach TG, Greene JG. Parkinson's disease is not associated with gastrointestinal myenteric ganglion neuron loss. Acta Neuropathol 2012;124:665-80. [PMID: 22941241 DOI: 10.1007/s00401-012-1040-2] [Cited by in Crossref: 132] [Cited by in F6Publishing: 123] [Article Influence: 13.2] [Reference Citation Analysis]
Number Citing Articles
1 Suzuki M, Nakamura T, Hirayama M, Ueda M, Katsuno M, Sobue G. Cardiac parasympathetic dysfunction in the early phase of Parkinson's disease. J Neurol 2017;264:333-40. [PMID: 27900499 DOI: 10.1007/s00415-016-8348-0] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 2.5] [Reference Citation Analysis]
2 Han MN, Finkelstein DI, Mcquade RM, Diwakarla S. Gastrointestinal Dysfunction in Parkinson’s Disease: Current and Potential Therapeutics. JPM 2022;12:144. [DOI: 10.3390/jpm12020144] [Reference Citation Analysis]
3 Bu LL, Huang KX, Zheng DZ, Lin DY, Chen Y, Jing XN, Liang YR, Tao EX. Alpha-Synuclein Accumulation and Its Phosphorylation in the Enteric Nervous System of Patients Without Neurodegeneration: An Explorative Study. Front Aging Neurosci 2020;12:575481. [PMID: 33328957 DOI: 10.3389/fnagi.2020.575481] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
4 Johnson M, Salvatore M, Maiolo S, Bobrovskaya L. Tyrosine hydroxylase as a sentinel for central and peripheral tissue responses in Parkinson’s progression: Evidence from clinical studies and neurotoxin models. Progress in Neurobiology 2018;165-167:1-25. [DOI: 10.1016/j.pneurobio.2018.01.002] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 4.5] [Reference Citation Analysis]
5 Urban P, Falkenburger B, Jost WH, Ransmayr G, Riederer P, Winkler C. [Structure and efferences of the substantia nigra pars compacta in Parkinson's disease]. Fortschr Neurol Psychiatr 2020;88:591-9. [PMID: 32396943 DOI: 10.1055/a-1149-9280] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
6 Zheng LF, Song J, Fan RF, Chen CL, Ren QZ, Zhang XL, Feng XY, Zhang Y, Li LS, Zhu JX. The role of the vagal pathway and gastric dopamine in the gastroparesis of rats after a 6-hydroxydopamine microinjection in the substantia nigra. Acta Physiol (Oxf) 2014;211:434-46. [PMID: 24410908 DOI: 10.1111/apha.12229] [Cited by in Crossref: 52] [Cited by in F6Publishing: 42] [Article Influence: 6.5] [Reference Citation Analysis]
7 Hilton D, Stephens M, Kirk L, Edwards P, Potter R, Zajicek J, Broughton E, Hagan H, Carroll C. Accumulation of α-synuclein in the bowel of patients in the pre-clinical phase of Parkinson's disease. Acta Neuropathol 2014;127:235-41. [PMID: 24240814 DOI: 10.1007/s00401-013-1214-6] [Cited by in Crossref: 200] [Cited by in F6Publishing: 176] [Article Influence: 25.0] [Reference Citation Analysis]
8 Jellinger KA. Neuropathology of Parkinson’s Disease. In: Thomas M, editor. Inflammation in Parkinson's Disease. Cham: Springer International Publishing; 2014. pp. 25-74. [DOI: 10.1007/978-3-319-08046-8_2] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
9 Schneider SA, Boettner M, Alexoudi A, Zorenkov D, Deuschl G, Wedel T. Can we use peripheral tissue biopsies to diagnose Parkinson's disease? A review of the literature. Eur J Neurol 2016;23:247-61. [PMID: 26100920 DOI: 10.1111/ene.12753] [Cited by in Crossref: 63] [Cited by in F6Publishing: 58] [Article Influence: 9.0] [Reference Citation Analysis]
10 Singh A, Dawson TM, Kulkarni S. Neurodegenerative disorders and gut-brain interactions. J Clin Invest 2021;131:143775. [PMID: 34196307 DOI: 10.1172/JCI143775] [Reference Citation Analysis]
11 Nakamori H, Noda K, Mitsui R, Hashitani H. Role of enteric dopaminergic neurons in regulating peristalsis of rat proximal colon. Neurogastroenterol Motil 2021;:e14127. [PMID: 33939231 DOI: 10.1111/nmo.14127] [Reference Citation Analysis]
12 Beach TG, Adler CH, Sue LI, Serrano G, Shill HA, Walker DG, Lue L, Roher AE, Dugger BN, Maarouf C, Birdsill AC, Intorcia A, Saxon-Labelle M, Pullen J, Scroggins A, Filon J, Scott S, Hoffman B, Garcia A, Caviness JN, Hentz JG, Driver-Dunckley E, Jacobson SA, Davis KJ, Belden CM, Long KE, Malek-Ahmadi M, Powell JJ, Gale LD, Nicholson LR, Caselli RJ, Woodruff BK, Rapscak SZ, Ahern GL, Shi J, Burke AD, Reiman EM, Sabbagh MN. Arizona Study of Aging and Neurodegenerative Disorders and Brain and Body Donation Program. Neuropathology 2015;35:354-89. [PMID: 25619230 DOI: 10.1111/neup.12189] [Cited by in Crossref: 192] [Cited by in F6Publishing: 170] [Article Influence: 27.4] [Reference Citation Analysis]
13 Lamotte G, Holmes C, Sullivan P, Lenka A, Goldstein DS. Cardioselective peripheral noradrenergic deficiency in Lewy body synucleinopathies. Ann Clin Transl Neurol 2020;7:2450-60. [PMID: 33216462 DOI: 10.1002/acn3.51243] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
14 Mukherjee A, Biswas A, Das SK. Gut dysfunction in Parkinson's disease. World J Gastroenterol 2016; 22(25): 5742-5752 [PMID: 27433087 DOI: 10.3748/wjg.v22.i25.5742] [Cited by in CrossRef: 79] [Cited by in F6Publishing: 66] [Article Influence: 13.2] [Reference Citation Analysis]
15 Pellegrini C, D'Antongiovanni V, Ippolito C, Segnani C, Antonioli L, Fornai M, Bernardini N. From the intestinal mucosal barrier to the enteric neuromuscular compartment: an integrated overview on the morphological changes in Parkinson's disease. Eur J Histochem 2021;65. [PMID: 34802221 DOI: 10.4081/ejh.2021.3278] [Reference Citation Analysis]
16 Chen Y, Shao Q, Yuan YH, Chen NH. Prion-like propagation of α-synuclein in the gut-brain axis. Brain Res Bull 2018;140:341-6. [PMID: 29894766 DOI: 10.1016/j.brainresbull.2018.06.002] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
17 Pfeiffer RF. Gastrointestinal Dysfunction in Parkinson's Disease. Curr Treat Options Neurol. 2018;20:54. [PMID: 30361783 DOI: 10.1007/s11940-018-0539-9] [Cited by in Crossref: 45] [Cited by in F6Publishing: 35] [Article Influence: 11.3] [Reference Citation Analysis]
18 Borghammer P. How does parkinson's disease begin? Perspectives on neuroanatomical pathways, prions, and histology. Mov Disord 2018;33:48-57. [PMID: 28843014 DOI: 10.1002/mds.27138] [Cited by in Crossref: 65] [Cited by in F6Publishing: 64] [Article Influence: 13.0] [Reference Citation Analysis]
19 Lamontagne-Proulx J, Coulombe K, Dahhani F, Côté M, Guyaz C, Tremblay C, Di Marzo V, Flamand N, Calon F, Soulet D. Effect of Docosahexaenoic Acid (DHA) at the Enteric Level in a Synucleinopathy Mouse Model. Nutrients 2021;13:4218. [PMID: 34959768 DOI: 10.3390/nu13124218] [Reference Citation Analysis]
20 Di ZS, Yang ZJ, Zhu MJ, Wang FF, Li LS, Xu JD. Regulation of intestinal epithelial barrier by and dysfunction of intestinal glial cells. Shijie Huaren Xiaohua Zazhi 2019; 27(16): 1013-1021 [DOI: 10.11569/wcjd.v27.i16.1013] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
21 Keshavarzian A, Engen P, Bonvegna S, Cilia R. The gut microbiome in Parkinson's disease: A culprit or a bystander? Prog Brain Res 2020;252:357-450. [PMID: 32247371 DOI: 10.1016/bs.pbr.2020.01.004] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 5.5] [Reference Citation Analysis]
22 Adler CH, Dugger BN, Hinni ML, Lott DG, Driver-Dunckley E, Hidalgo J, Henry-Watson J, Serrano G, Sue LI, Nagel T, Duffy A, Shill HA, Akiyama H, Walker DG, Beach TG. Submandibular gland needle biopsy for the diagnosis of Parkinson disease. Neurology 2014;82:858-64. [PMID: 24500652 DOI: 10.1212/WNL.0000000000000204] [Cited by in Crossref: 87] [Cited by in F6Publishing: 39] [Article Influence: 10.9] [Reference Citation Analysis]
23 Derkinderen P, Cossais F, de Guilhem de Lataillade A, Leclair-Visonneau L, Neunlist M, Paillusson S, De Giorgio R. Gastrointestinal mucosal biopsies in Parkinson's disease: beyond alpha-synuclein detection. J Neural Transm (Vienna) 2021. [PMID: 34816335 DOI: 10.1007/s00702-021-02445-6] [Reference Citation Analysis]
24 Poirier AA, Aubé B, Côté M, Morin N, Di Paolo T, Soulet D. Gastrointestinal Dysfunctions in Parkinson's Disease: Symptoms and Treatments. Parkinsons Dis 2016;2016:6762528. [PMID: 28050310 DOI: 10.1155/2016/6762528] [Cited by in Crossref: 28] [Cited by in F6Publishing: 34] [Article Influence: 4.7] [Reference Citation Analysis]
25 Garrido-Gil P, Rodriguez-Perez AI, Dominguez-Meijide A, Guerra MJ, Labandeira-Garcia JL. Bidirectional Neural Interaction Between Central Dopaminergic and Gut Lesions in Parkinson's Disease Models. Mol Neurobiol 2018;55:7297-316. [PMID: 29404956 DOI: 10.1007/s12035-018-0937-8] [Cited by in Crossref: 44] [Cited by in F6Publishing: 44] [Article Influence: 11.0] [Reference Citation Analysis]
26 Phillips RJ, Martin FN, Billingsley CN, Powley TL. Alpha-synuclein expression patterns in the colonic submucosal plexus of the aging Fischer 344 rat: implications for biopsies in aging and neurodegenerative disorders? Neurogastroenterol Motil 2013;25:e621-33. [PMID: 23809578 DOI: 10.1111/nmo.12176] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
27 Coletto E, Dolan JS, Pritchard S, Gant A, Hikima A, Jackson MJ, Benham CD, Chaudhuri KR, Rose S, Jenner P, Iravani MM. Contractile dysfunction and nitrergic dysregulation in small intestine of a primate model of Parkinson's disease. NPJ Parkinsons Dis 2019;5:10. [PMID: 31231674 DOI: 10.1038/s41531-019-0081-9] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]
28 Staff NP, Jones DT, Singer W. Mesenchymal Stromal Cell Therapies for Neurodegenerative Diseases. Mayo Clin Proc. 2019;94:892-905. [PMID: 31054608 DOI: 10.1016/j.mayocp.2019.01.001] [Cited by in Crossref: 37] [Cited by in F6Publishing: 33] [Article Influence: 12.3] [Reference Citation Analysis]
29 Manfredsson FP, Luk KC, Benskey MJ, Gezer A, Garcia J, Kuhn NC, Sandoval IM, Patterson JR, O'Mara A, Yonkers R, Kordower JH. Induction of alpha-synuclein pathology in the enteric nervous system of the rat and non-human primate results in gastrointestinal dysmotility and transient CNS pathology. Neurobiol Dis 2018;112:106-18. [PMID: 29341898 DOI: 10.1016/j.nbd.2018.01.008] [Cited by in Crossref: 67] [Cited by in F6Publishing: 69] [Article Influence: 16.8] [Reference Citation Analysis]
30 Deeb W, Nozile-Firth K, Okun MS. Parkinson's disease: Diagnosis and appreciation of comorbidities. Handb Clin Neurol 2019;167:257-77. [PMID: 31753136 DOI: 10.1016/B978-0-12-804766-8.00014-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
31 Côté M, Bourque M, Poirier A, Aubé B, Morissette M, Di Paolo T, Soulet D. GPER1-mediated immunomodulation and neuroprotection in the myenteric plexus of a mouse model of Parkinson's disease. Neurobiology of Disease 2015;82:99-113. [DOI: 10.1016/j.nbd.2015.05.017] [Cited by in Crossref: 31] [Cited by in F6Publishing: 28] [Article Influence: 4.4] [Reference Citation Analysis]
32 Klingelhoefer L, Reichmann H. Pathogenesis of Parkinson disease—the gut–brain axis and environmental factors. Nat Rev Neurol 2015;11:625-36. [DOI: 10.1038/nrneurol.2015.197] [Cited by in Crossref: 256] [Cited by in F6Publishing: 236] [Article Influence: 36.6] [Reference Citation Analysis]
33 Beach TG, Corbillé AG, Letournel F, Kordower JH, Kremer T, Munoz DG, Intorcia A, Hentz J, Adler CH, Sue LI, Walker J, Serrano G, Derkinderen P. Multicenter Assessment of Immunohistochemical Methods for Pathological Alpha-Synuclein in Sigmoid Colon of Autopsied Parkinson's Disease and Control Subjects. J Parkinsons Dis 2016;6:761-70. [PMID: 27589538 DOI: 10.3233/JPD-160888] [Cited by in Crossref: 43] [Cited by in F6Publishing: 23] [Article Influence: 8.6] [Reference Citation Analysis]
34 Lee JM, Derkinderen P, Kordower JH, Freeman R, Munoz DG, Kremer T, Zago W, Hutten SJ, Adler CH, Serrano GE, Beach TG. The Search for a Peripheral Biopsy Indicator of α-Synuclein Pathology for Parkinson Disease. J Neuropathol Exp Neurol. [DOI: 10.1093/jnen/nlw103] [Cited by in Crossref: 18] [Cited by in F6Publishing: 32] [Article Influence: 3.6] [Reference Citation Analysis]
35 Krygowska-Wajs A, Furgala A, Gorecka-Mazur A, Pietraszko W, Thor P, Potasz-Kulikowska K, Moskala M. The effect of subthalamic deep brain stimulation on gastric motility in Parkinson's disease. Parkinsonism Relat Disord 2016;26:35-40. [PMID: 26952698 DOI: 10.1016/j.parkreldis.2016.02.010] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 3.0] [Reference Citation Analysis]
36 Beach TG, Adler CH, Sue LI, Shill HA, Driver-Dunckley E, Mehta SH, Intorcia AJ, Glass MJ, Walker JE, Arce R, Nelson CM, Serrano GE. Vagus Nerve and Stomach Synucleinopathy in Parkinson's Disease, Incidental Lewy Body Disease, and Normal Elderly Subjects: Evidence Against the "Body-First" Hypothesis. J Parkinsons Dis 2021. [PMID: 34151862 DOI: 10.3233/JPD-212733] [Reference Citation Analysis]
37 Felice VD, Quigley EM, Sullivan AM, O'Keeffe GW, O'Mahony SM. Microbiota-gut-brain signalling in Parkinson's disease: Implications for non-motor symptoms. Parkinsonism Relat Disord 2016;27:1-8. [PMID: 27013171 DOI: 10.1016/j.parkreldis.2016.03.012] [Cited by in Crossref: 102] [Cited by in F6Publishing: 89] [Article Influence: 17.0] [Reference Citation Analysis]
38 Toti L, Travagli RA. Gastric dysregulation induced by microinjection of 6-OHDA in the substantia nigra pars compacta of rats is determined by alterations in the brain-gut axis. Am J Physiol Gastrointest Liver Physiol 2014;307:G1013-23. [PMID: 25277799 DOI: 10.1152/ajpgi.00258.2014] [Cited by in Crossref: 36] [Cited by in F6Publishing: 32] [Article Influence: 4.5] [Reference Citation Analysis]
39 Visanji NP, Marras C, Kern DS, Al Dakheel A, Gao A, Liu LW, Lang AE, Hazrati LN. Colonic mucosal a-synuclein lacks specificity as a biomarker for Parkinson disease. Neurology 2015;84:609-16. [PMID: 25589666 DOI: 10.1212/WNL.0000000000001240] [Cited by in Crossref: 102] [Cited by in F6Publishing: 40] [Article Influence: 14.6] [Reference Citation Analysis]
40 Scheperjans F, Derkinderen P, Borghammer P. The Gut and Parkinson's Disease: Hype or Hope? J Parkinsons Dis 2018;8:S31-9. [PMID: 30584161 DOI: 10.3233/JPD-181477] [Cited by in Crossref: 37] [Cited by in F6Publishing: 25] [Article Influence: 12.3] [Reference Citation Analysis]
41 Shultz JM, Resnikoff H, Bondarenko V, Joers V, Mejia A, Simmons H, Emborg ME. Neurotoxin-Induced Catecholaminergic Loss in the Colonic Myenteric Plexus of Rhesus Monkeys. J Alzheimers Dis Parkinsonism 2016;6:279. [PMID: 28090391 DOI: 10.4172/2161-0460.1000279] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
42 Bohnen NI, Kanel P, Müller MLTM. Molecular Imaging of the Cholinergic System in Parkinson's Disease. Int Rev Neurobiol 2018;141:211-50. [PMID: 30314597 DOI: 10.1016/bs.irn.2018.07.027] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 4.3] [Reference Citation Analysis]
43 Shin J, Park S, Shin C, Kim J, Yun TJ, Kim H, Jeon B. Submandibular gland is a suitable site for alpha synuclein pathology in Parkinson disease. Parkinsonism & Related Disorders 2019;58:35-9. [DOI: 10.1016/j.parkreldis.2018.04.019] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
44 Ellett LJ, Hung LW, Munckton R, Sherratt NA, Culvenor J, Grubman A, Furness JB, White AR, Finkelstein DI, Barnham KJ, Lawson VA. Restoration of intestinal function in an MPTP model of Parkinson's Disease. Sci Rep 2016;6:30269. [PMID: 27471168 DOI: 10.1038/srep30269] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 3.2] [Reference Citation Analysis]
45 Visanji NP, Marras C, Hazrati LN, Liu LW, Lang AE. Alimentary, my dear Watson? The challenges of enteric α-synuclein as a Parkinson's disease biomarker. Mov Disord 2014;29:444-50. [PMID: 24375496 DOI: 10.1002/mds.25789] [Cited by in Crossref: 59] [Cited by in F6Publishing: 57] [Article Influence: 6.6] [Reference Citation Analysis]
46 Bindas AJ, Kulkarni S, Koppes RA, Koppes AN. Parkinson's disease and the gut: Models of an emerging relationship. Acta Biomater 2021;132:325-44. [PMID: 33857691 DOI: 10.1016/j.actbio.2021.03.071] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
47 Ulusoy A, Phillips RJ, Helwig M, Klinkenberg M, Powley TL, Di Monte DA. Brain-to-stomach transfer of α-synuclein via vagal preganglionic projections. Acta Neuropathol 2017;133:381-93. [PMID: 28012041 DOI: 10.1007/s00401-016-1661-y] [Cited by in Crossref: 114] [Cited by in F6Publishing: 103] [Article Influence: 22.8] [Reference Citation Analysis]
48 Lee HJ, Jung KW, Chung SJ, Hong SM, Kim J, Lee JH, Hwang SW, Ryu HS, Kim MJ, Lee HS, Seo M, Park SH, Yang DH, Ye BD, Byeon JS, Choe J, Jung HY, Yang SK, Myung SJ. Relation of Enteric α-Synuclein to Gastrointestinal Dysfunction in Patients With Parkinson's Disease and in Neurologically Intact Subjects. J Neurogastroenterol Motil 2018;24:469-78. [PMID: 29969861 DOI: 10.5056/jnm17141] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.8] [Reference Citation Analysis]
49 Pellegrini C, Colucci R, Antonioli L, Barocelli E, Ballabeni V, Bernardini N, Blandizzi C, de Jonge WJ, Fornai M. Intestinal dysfunction in Parkinson's disease: Lessons learned from translational studies and experimental models. Neurogastroenterol Motil 2016;28:1781-91. [PMID: 27611012 DOI: 10.1111/nmo.12933] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 4.5] [Reference Citation Analysis]
50 Bendor JT, Logan TP, Edwards RH. The function of α-synuclein. Neuron 2013;79:1044-66. [PMID: 24050397 DOI: 10.1016/j.neuron.2013.09.004] [Cited by in Crossref: 407] [Cited by in F6Publishing: 367] [Article Influence: 45.2] [Reference Citation Analysis]
51 Schaffernicht G, Shang Q, Stievenard A, Bötzel K, Dening Y, Kempe R, Toussaint M, Gündel D, Kranz M, Reichmann H, Vanbesien-Mailliot C, Brust P, Dieterich M, Funk RHW, Ravens U, Pan-Montojo F. Pathophysiological Changes in the Enteric Nervous System of Rotenone-Exposed Mice as Early Radiological Markers for Parkinson's Disease. Front Neurol 2021;12:642604. [PMID: 33841309 DOI: 10.3389/fneur.2021.642604] [Reference Citation Analysis]
52 Beach TG, Adler CH, Dugger BN, Serrano G, Hidalgo J, Henry-Watson J, Shill HA, Sue LI, Sabbagh MN, Akiyama H; Arizona Parkinson’s Disease Consortium. Submandibular gland biopsy for the diagnosis of Parkinson disease. J Neuropathol Exp Neurol 2013;72:130-6. [PMID: 23334596 DOI: 10.1097/NEN.0b013e3182805c72] [Cited by in Crossref: 78] [Cited by in F6Publishing: 33] [Article Influence: 8.7] [Reference Citation Analysis]
53 Johnson ME, Zhou XF, Bobrovskaya L. The effects of rotenone on TH, BDNF and BDNF-related proteins in the brain and periphery: Relevance to early Parkinson's disease. J Chem Neuroanat 2019;97:23-32. [PMID: 30690135 DOI: 10.1016/j.jchemneu.2019.01.010] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
54 Uchihara T, Giasson BI. Propagation of alpha-synuclein pathology: hypotheses, discoveries, and yet unresolved questions from experimental and human brain studies. Acta Neuropathol 2016;131:49-73. [PMID: 26446103 DOI: 10.1007/s00401-015-1485-1] [Cited by in Crossref: 132] [Cited by in F6Publishing: 114] [Article Influence: 22.0] [Reference Citation Analysis]
55 Giancola F, Torresan F, Repossi R, Bianco F, Latorre R, Ioannou A, Guarino M, Volta U, Clavenzani P, Mazzoni M, Chiocchetti R, Bazzoli F, Travagli RA, Sternini C, De Giorgio R. Downregulation of neuronal vasoactive intestinal polypeptide in Parkinson's disease and chronic constipation. Neurogastroenterol Motil 2017;29. [PMID: 27891695 DOI: 10.1111/nmo.12995] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 3.0] [Reference Citation Analysis]
56 Gjerløff T, Fedorova T, Knudsen K, Munk OL, Nahimi A, Jacobsen S, Danielsen EH, Terkelsen AJ, Hansen J, Pavese N, Brooks DJ, Borghammer P. Imaging acetylcholinesterase density in peripheral organs in Parkinson's disease with 11C-donepezil PET. Brain 2015;138:653-63. [PMID: 25539902 DOI: 10.1093/brain/awu369] [Cited by in Crossref: 91] [Cited by in F6Publishing: 76] [Article Influence: 11.4] [Reference Citation Analysis]
57 Hagl CI, Heumüller-Klug S, Wink E, Wessel L, Schäfer KH. The human gastrointestinal tract, a potential autologous neural stem cell source. PLoS One 2013;8:e72948. [PMID: 24023797 DOI: 10.1371/journal.pone.0072948] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.9] [Reference Citation Analysis]
58 Rosenberg HJ, Rao M. Enteric glia in homeostasis and disease: From fundamental biology to human pathology. iScience 2021;24:102863. [PMID: 34401661 DOI: 10.1016/j.isci.2021.102863] [Reference Citation Analysis]
59 Cossais F, Schaeffer E, Heinzel S, Zimmermann J, Niesler B, Röth R, Rappold G, Scharf A, Zorenkov D, Lange C, Barrenschee M, Margraf NG, Ellrichmann M, Berg D, Böttner M, Wedel T. Expression Profiling of Rectal Biopsies Suggests Altered Enteric Neuropathological Traits in Parkinson's Disease Patients. J Parkinsons Dis 2021;11:171-6. [PMID: 33337386 DOI: 10.3233/JPD-202258] [Reference Citation Analysis]
60 Epprecht L, Schreglmann SR, Goetze O, Woitalla D, Baumann CR, Waldvogel D. Unchanged gastric emptying and visceral perception in early Parkinson's disease after a high caloric test meal. J Neurol 2015;262:1946-53. [DOI: 10.1007/s00415-015-7799-z] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
61 Soliman H, Coffin B, Gourcerol G. Gastroparesis in Parkinson Disease: Pathophysiology, and Clinical Management. Brain Sci 2021;11:831. [PMID: 34201699 DOI: 10.3390/brainsci11070831] [Reference Citation Analysis]
62 Harapan BN, Frydrychowicz C, Classen J, Wittekind C, Gradistanac T, Rumpf JJ, Mueller W. No enhanced (p-) α-synuclein deposition in gastrointestinal tissue of Parkinson's disease patients. Parkinsonism Relat Disord 2020;80:82-8. [PMID: 32971383 DOI: 10.1016/j.parkreldis.2020.08.020] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
63 Braidy N, Gai WP, Xu YH, Sachdev P, Guillemin GJ, Jiang XM, Ballard JW, Horan MP, Fang ZM, Chong BH, Chan DK. Alpha-synuclein transmission and mitochondrial toxicity in primary human foetal enteric neurons in vitro. Neurotox Res 2014;25:170-82. [PMID: 24026637 DOI: 10.1007/s12640-013-9420-5] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 1.7] [Reference Citation Analysis]
64 Mozaffari S, Nikfar S, Daniali M, Abdollahi M. The pharmacological management of constipation in patients with Parkinson's disease: a much-needed relief. Expert Opin Pharmacother 2020;21:701-7. [PMID: 32037901 DOI: 10.1080/14656566.2020.1726319] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
65 Mou L, Ding W, Fernandez-Funez P. Open questions on the nature of Parkinson's disease: from triggers to spreading pathology. J Med Genet 2020;57:73-81. [PMID: 31484719 DOI: 10.1136/jmedgenet-2019-106210] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
66 Jia F, Song N, Zhao C, Xie J, Jiang H. Unexpected improvements of spatial learning and memory abilities in chronic rotenone intoxicated mice. PLoS One 2014;9:e91641. [PMID: 24618574 DOI: 10.1371/journal.pone.0091641] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
67 Unger MM, Sakakibara R. Does REM sleep behavior disorder have the guts to be Parkinson disease? Neurology 2015;85:1732-3. [DOI: 10.1212/wnl.0000000000002130] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
68 Fornai M, Pellegrini C, Antonioli L, Segnani C, Ippolito C, Barocelli E, Ballabeni V, Vegezzi G, Al Harraq Z, Blandini F, Levandis G, Cerri S, Blandizzi C, Bernardini N, Colucci R. Enteric Dysfunctions in Experimental Parkinson's Disease: Alterations of Excitatory Cholinergic Neurotransmission Regulating Colonic Motility in Rats. J Pharmacol Exp Ther. 2016;356:434-444. [PMID: 26582732 DOI: 10.1124/jpet.115.228510] [Cited by in Crossref: 25] [Cited by in F6Publishing: 28] [Article Influence: 3.6] [Reference Citation Analysis]
69 Bencsik A, Muselli L, Leboidre M, Lakhdar L, Baron T. Early and persistent expression of phosphorylated α-synuclein in the enteric nervous system of A53T mutant human α-synuclein transgenic mice. J Neuropathol Exp Neurol 2014;73:1144-51. [PMID: 25383638 DOI: 10.1097/NEN.0000000000000137] [Cited by in Crossref: 23] [Cited by in F6Publishing: 14] [Article Influence: 3.3] [Reference Citation Analysis]
70 Fedorova TD, Seidelin LB, Knudsen K, Schacht AC, Geday J, Pavese N, Brooks DJ, Borghammer P. Decreased intestinal acetylcholinesterase in early Parkinson disease: An 11 C-donepezil PET study. Neurology 2017;88:775-81. [DOI: 10.1212/wnl.0000000000003633] [Cited by in Crossref: 43] [Cited by in F6Publishing: 19] [Article Influence: 8.6] [Reference Citation Analysis]
71 Barrenschee M, Zorenkov D, Böttner M, Lange C, Cossais F, Scharf AB, Deuschl G, Schneider SA, Ellrichmann M, Fritscher-Ravens A, Wedel T. Distinct pattern of enteric phospho-alpha-synuclein aggregates and gene expression profiles in patients with Parkinson's disease. Acta Neuropathol Commun 2017;5:1. [PMID: 28057070 DOI: 10.1186/s40478-016-0408-2] [Cited by in Crossref: 54] [Cited by in F6Publishing: 47] [Article Influence: 10.8] [Reference Citation Analysis]
72 Goedert M, Jakes R, Spillantini MG. The Synucleinopathies: Twenty Years On. J Parkinsons Dis 2017;7:S51-69. [PMID: 28282814 DOI: 10.3233/JPD-179005] [Cited by in Crossref: 141] [Cited by in F6Publishing: 111] [Article Influence: 28.2] [Reference Citation Analysis]
73 Natale G, Ryskalin L, Morucci G, Lazzeri G, Frati A, Fornai F. The Baseline Structure of the Enteric Nervous System and Its Role in Parkinson's Disease. Life (Basel) 2021;11:732. [PMID: 34440476 DOI: 10.3390/life11080732] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
74 Pasquini J, Brooks DJ, Pavese N. The Cholinergic Brain in Parkinson's Disease. Mov Disord Clin Pract 2021;8:1012-26. [PMID: 34631936 DOI: 10.1002/mdc3.13319] [Reference Citation Analysis]
75 Tanei ZI, Saito Y, Ito S, Matsubara T, Motoda A, Yamazaki M, Sakashita Y, Kawakami I, Ikemura M, Tanaka S, Sengoku R, Arai T, Murayama S. Lewy pathology of the esophagus correlates with the progression of Lewy body disease: a Japanese cohort study of autopsy cases. Acta Neuropathol 2021;141:25-37. [PMID: 33150517 DOI: 10.1007/s00401-020-02233-8] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 21.0] [Reference Citation Analysis]
76 Kubo S. Membrane lipids as therapeutic targets for Parkinson’s disease: a possible link between Lewy pathology and membrane lipids. Expert Opinion on Therapeutic Targets 2015;20:1301-10. [DOI: 10.1517/14728222.2016.1086340] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
77 Sharabi Y, Vatine GD, Ashkenazi A. Parkinson's disease outside the brain: targeting the autonomic nervous system. Lancet Neurol 2021;20:868-76. [PMID: 34536407 DOI: 10.1016/S1474-4422(21)00219-2] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
78 O'Donovan SM, Crowley EK, Brown JR, O'Sullivan O, O'Leary OF, Timmons S, Nolan YM, Clarke DJ, Hyland NP, Joyce SA, Sullivan AM, O'Neill C. Nigral overexpression of α-synuclein in a rat Parkinson's disease model indicates alterations in the enteric nervous system and the gut microbiome. Neurogastroenterol Motil 2020;32:e13726. [PMID: 31576631 DOI: 10.1111/nmo.13726] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 6.7] [Reference Citation Analysis]
79 Resnikoff H, Metzger JM, Lopez M, Bondarenko V, Mejia A, Simmons HA, Emborg ME. Colonic inflammation affects myenteric alpha-synuclein in nonhuman primates. J Inflamm Res 2019;12:113-26. [PMID: 31123415 DOI: 10.2147/JIR.S196552] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
80 Guan X, Wang Y, Li Q, Wei M, Chen L, Cheng O. Analysis of the clinical features of early Parkinson's disease with comparatively integrated intestinal function. Neurol Sci 2018;39:1847-56. [PMID: 30019200 DOI: 10.1007/s10072-018-3502-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
81 Knowles CH, Lindberg G, Panza E, De Giorgio R. New perspectives in the diagnosis and management of enteric neuropathies. Nat Rev Gastroenterol Hepatol. 2013;10:206-218. [PMID: 23399525 DOI: 10.1038/nrgastro.2013.18] [Cited by in Crossref: 75] [Cited by in F6Publishing: 60] [Article Influence: 8.3] [Reference Citation Analysis]
82 Leclair-visonneau L, Magy L, Volteau C, Clairembault T, Le Dily S, Préterre C, Peyre A, Damier P, Neunlist M, Péréon Y, Derkinderen P. Heterogeneous pattern of autonomic dysfunction in Parkinson’s disease. J Neurol 2018;265:933-41. [DOI: 10.1007/s00415-018-8789-8] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 4.3] [Reference Citation Analysis]
83 Lindahl M, Chalazonitis A, Palm E, Pakarinen E, Danilova T, Pham TD, Setlik W, Rao M, Võikar V, Huotari J, Kopra J, Andressoo JO, Piepponen PT, Airavaara M, Panhelainen A, Gershon MD, Saarma M. Cerebral dopamine neurotrophic factor-deficiency leads to degeneration of enteric neurons and altered brain dopamine neuronal function in mice. Neurobiol Dis 2020;134:104696. [PMID: 31783118 DOI: 10.1016/j.nbd.2019.104696] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
84 Sprenger FS, Stefanova N, Gelpi E, Seppi K, Navarro-Otano J, Offner F, Vilas D, Valldeoriola F, Pont-Sunyer C, Aldecoa I, Gaig C, Gines A, Cuatrecasas M, Högl B, Frauscher B, Iranzo A, Wenning GK, Vogel W, Tolosa E, Poewe W. Enteric nervous system α-synuclein immunoreactivity in idiopathic REM sleep behavior disorder. Neurology 2015;85:1761-8. [PMID: 26475692 DOI: 10.1212/WNL.0000000000002126] [Cited by in Crossref: 89] [Cited by in F6Publishing: 29] [Article Influence: 12.7] [Reference Citation Analysis]
85 Greene JG. Causes and consequences of degeneration of the dorsal motor nucleus of the vagus nerve in Parkinson's disease. Antioxid Redox Signal 2014;21:649-67. [PMID: 24597973 DOI: 10.1089/ars.2014.5859] [Cited by in Crossref: 43] [Cited by in F6Publishing: 41] [Article Influence: 5.4] [Reference Citation Analysis]
86 Metzger JM, Emborg ME. Autonomic dysfunction in Parkinson disease and animal models. Clin Auton Res 2019;29:397-414. [PMID: 30604165 DOI: 10.1007/s10286-018-00584-7] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 6.3] [Reference Citation Analysis]
87 Chiang HL, Lin CH. Altered Gut Microbiome and Intestinal Pathology in Parkinson's Disease. J Mov Disord 2019;12:67-83. [PMID: 31158941 DOI: 10.14802/jmd.18067] [Cited by in Crossref: 27] [Cited by in F6Publishing: 23] [Article Influence: 9.0] [Reference Citation Analysis]
88 Kelly LP, Carvey PM, Keshavarzian A, Shannon KM, Shaikh M, Bakay RA, Kordower JH. Progression of intestinal permeability changes and alpha-synuclein expression in a mouse model of Parkinson's disease. Mov Disord. 2014;29:999-1009. [PMID: 24898698 DOI: 10.1002/mds.25736] [Cited by in Crossref: 115] [Cited by in F6Publishing: 110] [Article Influence: 12.8] [Reference Citation Analysis]
89 Jellinger KA. The pathomechanisms underlying Parkinson's disease. Expert Review of Neurotherapeutics 2014;14:199-215. [DOI: 10.1586/14737175.2014.877842] [Cited by in Crossref: 43] [Cited by in F6Publishing: 36] [Article Influence: 5.4] [Reference Citation Analysis]
90 Shin C, Yang H, Park S, Lee H, Kong S, Suh Y, Huh Y, Kim Y, Park S, Ahn T, Lee SH, Kim H, Jeon B. Prospective cohort study of patients with early gastric cancer to detect prodromal Parkinson disease (EGC-PPD): A study protocol and baseline characteristics. Journal of Clinical Neuroscience 2019;66:26-32. [DOI: 10.1016/j.jocn.2019.05.033] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
91 Schapira AHV, Chaudhuri KR, Jenner P. Non-motor features of Parkinson disease. Nat Rev Neurosci 2017;18:435-50. [PMID: 28592904 DOI: 10.1038/nrn.2017.62] [Cited by in Crossref: 429] [Cited by in F6Publishing: 407] [Article Influence: 85.8] [Reference Citation Analysis]
92 Poirier A, Côté M, Bourque M, Morissette M, Di Paolo T, Soulet D. Neuroprotective and immunomodulatory effects of raloxifene in the myenteric plexus of a mouse model of Parkinson's disease. Neurobiology of Aging 2016;48:61-71. [DOI: 10.1016/j.neurobiolaging.2016.08.004] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.3] [Reference Citation Analysis]
93 Giguère N, Burke Nanni S, Trudeau LE. On Cell Loss and Selective Vulnerability of Neuronal Populations in Parkinson's Disease. Front Neurol 2018;9:455. [PMID: 29971039 DOI: 10.3389/fneur.2018.00455] [Cited by in Crossref: 101] [Cited by in F6Publishing: 87] [Article Influence: 25.3] [Reference Citation Analysis]
94 Stokholm MG, Danielsen EH, Hamilton-dutoit SJ, Borghammer P. Pathological α-synuclein in gastrointestinal tissues from prodromal Parkinson disease patients: α-Synuclein in Prodromal PD. Ann Neurol 2016;79:940-9. [DOI: 10.1002/ana.24648] [Cited by in Crossref: 170] [Cited by in F6Publishing: 159] [Article Influence: 28.3] [Reference Citation Analysis]
95 Jellinger KA. Neuropathology of Nonmotor Symptoms of Parkinson's Disease. Int Rev Neurobiol 2017;133:13-62. [PMID: 28802920 DOI: 10.1016/bs.irn.2017.05.005] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 4.6] [Reference Citation Analysis]
96 Pietraszko W, Furgala A, Gorecka-Mazur A, Kwinta B, Kaszuba-Zwoinska J, Polak J, Fiszer U, Gil K, Krygowska-Wajs A. Assessments of plasma acyl-ghrelin levels in Parkinson's disease patients treated with deep brain stimulation. Peptides 2020;128:170299. [PMID: 32305796 DOI: 10.1016/j.peptides.2020.170299] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
97 Rouaud T, Corbillé AG, Leclair-Visonneau L, de Guilhem de Lataillade A, Lionnet A, Preterre C, Damier P, Derkinderen P. Pathophysiology of Parkinson's disease: Mitochondria, alpha-synuclein and much more…. Rev Neurol (Paris) 2021;177:260-71. [PMID: 33032797 DOI: 10.1016/j.neurol.2020.07.016] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
98 Rao M, Gershon MD. The bowel and beyond: the enteric nervous system in neurological disorders. Nat Rev Gastroenterol Hepatol. 2016;13:517-528. [PMID: 27435372 DOI: 10.1038/nrgastro.2016.107] [Cited by in Crossref: 204] [Cited by in F6Publishing: 172] [Article Influence: 34.0] [Reference Citation Analysis]
99 Travagli RA, Anselmi L. Vagal neurocircuitry and its influence on gastric motility. Nat Rev Gastroenterol Hepatol. 2016;13:389-401. [PMID: 27251213 DOI: 10.1038/nrgastro.2016.76] [Cited by in Crossref: 115] [Cited by in F6Publishing: 99] [Article Influence: 19.2] [Reference Citation Analysis]
100 Ramprasad C, Douglas JY, Moshiree B. Parkinson's Disease and Current Treatments for Its Gastrointestinal Neurogastromotility Effects. Curr Treat Options Gastroenterol 2018;16:489-510. [PMID: 30361854 DOI: 10.1007/s11938-018-0201-3] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
101 Wakabayashi K. Where and how alpha-synuclein pathology spreads in Parkinson's disease. Neuropathology 2020;40:415-25. [PMID: 32750743 DOI: 10.1111/neup.12691] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
102 Prigent A, Lionnet A, Corbillé A, Derkinderen P. Neuropathologie et physiopathologie de la maladie de Parkinson : focus sur l’α-synucléine. La Presse Médicale 2017;46:182-6. [DOI: 10.1016/j.lpm.2016.11.010] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
103 Engelender S, Isacson O. The Threshold Theory for Parkinson's Disease. Trends Neurosci 2017;40:4-14. [PMID: 27894611 DOI: 10.1016/j.tins.2016.10.008] [Cited by in Crossref: 97] [Cited by in F6Publishing: 94] [Article Influence: 16.2] [Reference Citation Analysis]
104 Kostrzewa RM. Neonatal 6-hydroxydopamine lesioning of rats and dopaminergic neurotoxicity: proposed animal model of Parkinson’s disease. J Neural Transm. [DOI: 10.1007/s00702-022-02479-4] [Reference Citation Analysis]
105 Leclair-Visonneau L, Neunlist M, Derkinderen P, Lebouvier T. The gut in Parkinson's disease: Bottom-up, top-down, or neither? Neurogastroenterol Motil 2020;32:e13777. [PMID: 31854093 DOI: 10.1111/nmo.13777] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 18.0] [Reference Citation Analysis]
106 Adler CH, Beach TG. Neuropathological basis of nonmotor manifestations of Parkinson's disease. Mov Disord 2016;31:1114-9. [PMID: 27030013 DOI: 10.1002/mds.26605] [Cited by in Crossref: 105] [Cited by in F6Publishing: 103] [Article Influence: 17.5] [Reference Citation Analysis]
107 Fasano A, Visanji NP, Liu LWC, Lang AE, Pfeiffer RF. Gastrointestinal dysfunction in Parkinson's disease. The Lancet Neurology 2015;14:625-39. [DOI: 10.1016/s1474-4422(15)00007-1] [Cited by in Crossref: 349] [Cited by in F6Publishing: 163] [Article Influence: 49.9] [Reference Citation Analysis]
108 Borghammer P, Knudsen K, Brooks DJ. Imaging Systemic Dysfunction in Parkinson’s Disease. Curr Neurol Neurosci Rep 2016;16. [DOI: 10.1007/s11910-016-0655-4] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
109 Clairembault T, Leclair-Visonneau L, Neunlist M, Derkinderen P. Enteric glial cells: new players in Parkinson’s disease? Mov Disord. 2015;30:494-498. [PMID: 25100667 DOI: 10.1002/mds.25979] [Cited by in Crossref: 62] [Cited by in F6Publishing: 54] [Article Influence: 7.8] [Reference Citation Analysis]
110 Akazawa Y, Hayashi T, Saito T, Niwa K, Kamiyama H, Sasahara N, Sakamoto K, Nagahara A, Yao T. Histological characteristics of eosinophilic myenteric ganglionitis: an under-recognised cause of chronic intestinal pseudo-obstruction. Virchows Arch 2019;474:395-400. [DOI: 10.1007/s00428-018-02513-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
111 Zhong CB, Chen QQ, Haikal C, Li W, Svanbergsson A, Diepenbroek M, Li JY. Age-Dependent Alpha-Synuclein Accumulation and Phosphorylation in the Enteric Nervous System in a Transgenic Mouse Model of Parkinson's Disease. Neurosci Bull 2017;33:483-92. [PMID: 28924920 DOI: 10.1007/s12264-017-0179-1] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
112 Corbillé AG, Clairembault T, Coron E, Leclair-Visonneau L, Preterre C, Neunlist M, Derkinderen P. What a gastrointestinal biopsy can tell us about Parkinson's disease? Neurogastroenterol Motil 2016;28:966-74. [PMID: 26914487 DOI: 10.1111/nmo.12797] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 3.0] [Reference Citation Analysis]
113 Côté M, Poirier A, Aubé B, Jobin C, Lacroix S, Soulet D. Partial depletion of the proinflammatory monocyte population is neuroprotective in the myenteric plexus but not in the basal ganglia in a MPTP mouse model of Parkinson’s disease. Brain, Behavior, and Immunity 2015;46:154-67. [DOI: 10.1016/j.bbi.2015.01.009] [Cited by in Crossref: 31] [Cited by in F6Publishing: 30] [Article Influence: 4.4] [Reference Citation Analysis]
114 Orimo S, Ghebremedhin E, Gelpi E. Peripheral and central autonomic nervous system: does the sympathetic or parasympathetic nervous system bear the brunt of the pathology during the course of sporadic PD? Cell Tissue Res 2018;373:267-86. [PMID: 29869180 DOI: 10.1007/s00441-018-2851-9] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 4.5] [Reference Citation Analysis]
115 Hauser RA, Sutherland D, Madrid JA, Rol MA, Frucht S, Isaacson S, Pagan F, Maddux BN, Li G, Tse W, Walter BL, Kumar R, Kremens D, Lew MF, Ellenbogen A, Oguh O, Vasquez A, Kinney W, Lowery M, Resnick M, Huff N, Posner J, Ballman KV, Harvey BE, Camilleri M, Zasloff M, Barbut D. Targeting neurons in the gastrointestinal tract to treat Parkinson's disease. Clin Park Relat Disord 2019;1:2-7. [PMID: 34316590 DOI: 10.1016/j.prdoa.2019.06.001] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]
116 Skjærbæk C, Knudsen K, Horsager J, Borghammer P. Gastrointestinal Dysfunction in Parkinson's Disease. J Clin Med 2021;10:493. [PMID: 33572547 DOI: 10.3390/jcm10030493] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
117 Goedert M, Spillantini MG, Del Tredici K, Braak H. 100 years of Lewy pathology. Nat Rev Neurol 2013;9:13-24. [DOI: 10.1038/nrneurol.2012.242] [Cited by in Crossref: 620] [Cited by in F6Publishing: 566] [Article Influence: 62.0] [Reference Citation Analysis]
118 Ohlsson B, Englund E. Atrophic Myenteric and Submucosal Neurons Are Observed in Parkinson's Disease. Parkinsons Dis 2019;2019:7935820. [PMID: 31321021 DOI: 10.1155/2019/7935820] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
119 Shin C, Park S, Yun JY, Shin JH, Yang H, Lee H, Kong S, Suh Y, Shen G, Kim Y, Kim H, Jeon B. Fundamental limit of alpha-synuclein pathology in gastrointestinal biopsy as a pathologic biomarker of Parkinson’s disease: Comparison with surgical specimens. Parkinsonism & Related Disorders 2017;44:73-8. [DOI: 10.1016/j.parkreldis.2017.09.001] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 3.2] [Reference Citation Analysis]
120 Nadeau J, Smith T, Lamontagne-proulx J, Bourque M, Al Sweidi S, Jayasinghe D, Ritchie S, Di Paolo T, Soulet D. Neuroprotection and immunomodulation in the gut of parkinsonian mice with a plasmalogen precursor. Brain Research 2019;1725:146460. [DOI: 10.1016/j.brainres.2019.146460] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
121 Ruffmann C, Parkkinen L. Gut Feelings About α-Synuclein in Gastrointestinal Biopsies: Biomarker in the Making? Mov Disord 2016;31:193-202. [PMID: 26799450 DOI: 10.1002/mds.26480] [Cited by in Crossref: 43] [Cited by in F6Publishing: 42] [Article Influence: 7.2] [Reference Citation Analysis]
122 Song N, Wang W, Jia F, Du X, Xie A, He Q, Shen X, Zhang J, Rogers JT, Xie J, Jiang H. Assessments of plasma ghrelin levels in the early stages of parkinson's disease. Mov Disord 2017;32:1487-91. [PMID: 28681931 DOI: 10.1002/mds.27095] [Cited by in Crossref: 29] [Cited by in F6Publishing: 24] [Article Influence: 5.8] [Reference Citation Analysis]
123 Levandis G, Balestra B, Siani F, Rizzo V, Ghezzi C, Ambrosi G, Cerri S, Bonizzi A, Vicini R, Vairetti M, Ferrigno A, Pastoris O, Blandini F. Response of colonic motility to dopaminergic stimulation is subverted in rats with nigrostriatal lesion: relevance to gastrointestinal dysfunctions in Parkinson's disease. Neurogastroenterol Motil 2015;27:1783-95. [DOI: 10.1111/nmo.12691] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.3] [Reference Citation Analysis]